DCMM
BIIB icon

DG Capital Management (Massachusetts)’s Biogen BIIB Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.7M Buy
+8,630
New +$2.56M 2.66% 11
2016
Q2 		– Sell
-5,599
Closed -$1.46M – 60
2016
Q1 		$1.46M Sell
5,599
-2,015
-26% -$532K 1.43% 29
2015
Q4 		$2.33M Sell
7,614
-4,190
-35% -$1.2M 2.08% 18
2015
Q3 		$3.44M Sell
11,804
-8,070
-41% -$2.66M 2.32% 13
2015
Q2 		$8.03M Buy
19,874
+2,090
+12% +$839K 4.84% 1
2015
Q1 		$7.51M Sell
17,784
-9,305
-34% -$3.67M 4.52% 1
2014
Q4 		$9.2M Sell
27,089
-826
-3% -$267K 5.33% 1
2014
Q3 		$9.23M Buy
27,915
+435
+2% +$143K 5.63% 1
2014
Q2 		$8.66M Sell
27,480
-225
-0.8% -$67.7K 4.94% 1
2014
Q1 		$8.47M Sell
27,705
-3,055
-10% -$970K 5.01% 2
2013
Q4 		$8.6M Buy
30,760
+510
+2% +$132K 4.79% 1
2013
Q3 		$7.28M Buy
30,250
+495
+2% +$111K 4.13% 1
2013
Q2 		$6.4M Buy
+29,755
New +$6.36M 3.88% 1

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DG Capital Management (Massachusetts)'s BIIB Position: Q3 2016 in Review

DG Capital Management (Massachusetts) opened a new position in Biogen (BIIB) in Q3 2016: 8,630 shares worth $2.7M. The stake represents 2.66% of the portfolio and ranks #11 among its holdings. This is a return to the name: DG Capital Management (Massachusetts) previously reported a position in BIIB as recently as Q1 2016.

DG Capital Management (Massachusetts) first reported a position in BIIB in Q2 2013 and has held it in 13 quarters since. The position peaked at $9.23M in Q3 2014. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • DG Capital Management (Massachusetts) held 8,630 shares of Biogen worth $2.7M as of Q3 2016.
  • Biogen was a new DG Capital Management (Massachusetts) position in Q3 2016.
  • Biogen made up 2.66% of DG Capital Management (Massachusetts)'s portfolio in Q3 2016, its #11 holding.
  • DG Capital Management (Massachusetts) first reported a position in Biogen in Q2 2013 and has held it in 13 quarters since.
  • DG Capital Management (Massachusetts)'s Biogen position peaked at $9.23M in Q3 2014.
  • 1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.